Boom Or Bust? Where Will Organogenesis Holdings Inc (NASDAQ: ORGO) Stock Go Next?

During the recent session, Organogenesis Holdings Inc (NASDAQ:ORGO)’s traded shares were 0.67 million, with the beta value of the company hitting 1.54. At the last check today, the stock’s price was $2.34, reflecting an intraday loss of -21.51% or -$0.64. The 52-week high for the ORGO share is $4.70, that puts it down -100.85 from that peak though still a striking 23.5% gain since the share price plummeted to a 52-week low of $1.79. The company’s market capitalization is $308.65M, and the average trade volume was 795.10K shares over the past three months.

Organogenesis Holdings Inc (NASDAQ:ORGO) trade information

Organogenesis Holdings Inc (ORGO) registered a -21.51% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -21.51% in intraday trading to $2.34, hitting a weekly high. The stock’s 5-day price performance is -18.22%, and it has moved by -10.73% in 30 days. Based on these gigs, the overall price performance for the year is 19.34%.

Organogenesis Holdings Inc (ORGO) estimates and forecasts

Statistics show that Organogenesis Holdings Inc has underperformed its competitors in share price, compared to the industry in which it operates. Organogenesis Holdings Inc (ORGO) shares have gone up 1.26% during the last six months, with a year-to-date growth rate less than the industry average at -125.00% against 10.20. In the rating firms’ projections, revenue will increase 5.00% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 101.05M as predicted by 2 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to 114.25M by the end of current fiscal year.

While earnings are projected to return -93.21% in 2024, the next five years will return 2.41% per annum.

ORGO Dividends

Organogenesis Holdings Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Organogenesis Holdings Inc (NASDAQ:ORGO)’s Major holders